# FDA recall D-1271-2020

> **Mylan Institutional LLC** · Class II · drug recall initiated 2020-05-05.

## Product

Aloprim (allopurinol sodium) for Injection, 500 mg Single-Dose Vial, Rx only, Manufactured for: Mylan Institutional LLC, Rockford, IL 61103 USA.  NDC: 67457-187-50

## Reason for recall

Discoloration: Out-of-specification results for appearance obtained during routine stability testing at the end of shelf-life for the parameters Appearance and Color of Solution.

## Distribution

Distributed Nationwide in the USA

## Key facts

- **Recall number:** D-1271-2020
- **Recalling firm:** Mylan Institutional LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-05-05
- **Report date:** 2020-05-27
- **Termination date:** 2022-01-26

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Rockford, IL, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1271-2020

## Citation

> AI Analytics. FDA recall D-1271-2020. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-1271-2020. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*